Lupin Pharmaceuticals recalls 20mg Quinapril tablets due to N-Nitroso impurity exceeding safety limits. Affected lots may pose health risks. Contact for return instructions.
CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.
Take action
Contact the company
📍Recalling firmLupin Pharmaceuticals Inc.Harborplace Tower, 111 S Calvert St Fl 21st · Baltimore, MD 21202-6174
✎ GovInfoNow plain-language explainer
Lupin Pharmaceuticals is recalling 20mg Quinapril tablets (90-pack) because they contain an impurity that could exceed safe levels. This recall affects prescription-only medication that was manufactured in specific lots and may pose health risks if taken. Read more at govinfonow.com/recall/34194-lupin-quinapril-tablets-20mg-recall-n-nitroso-impurity-risk.
“Lupin Quinapril Tablets 20mg Recall: N-Nitroso Impurity Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34194-lupin-quinapril-tablets-20mg-recall-n-nitroso-impurity-risk. Based on FDA recall #D-0089-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0089-2023%22&limit=1).
Lupin Pharmaceuticals Inc. recalled Quinapril Tablets USP, 20 mg (90 pack) on Dec. 7, 2022, due to CGMP deviations involving an impurity above acceptable limits, the FDA said. The voluntary Class II recall affects 23,736 units distributed nationwide.
How to tell if you have it
Brand: Lupin
Product: Quinapril Tablets USP, 20 mg (90 pack), Rx Only
NDC#: 68180-558-09
Lot #: G102929
Expiration: 04/2023
The hazard
The recall addresses CGMP deviations related to the detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit, according to the FDA.
Context
GovInfoNow's records show Lupin Pharmaceuticals Inc. has had 90 other recalls since Jan. 31, 2013. Recent brand actions include a Lupin Clobetasol Cream recall on Aug. 3, 2026, for failed content uniformity and a Lupin Glucagon Emergency Kit recall on June 23, 2026, for CGMP deviation risk. Other recent recalls of similar products include Asclemed Duloxetine Capsules Recall (May 14, 2026), Zydus Mirabegron 25mg Tablets Recall (Aug. 5, 2026), and Cipla Cinacalcet Tablets Recall (Nov. 14, 2025).
How to tell if you have this one
Check for the product name 'Quinapril Tablets USP 20mg (90 pack)', prescription-only status, and lot number G102929 (expiring April 2023). The NDC code 68180-558-09 is also a key identifier.
Brand
Lupin
Category
Drug
FDA recall event · 2 products
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
Classification
Class II
Status
Terminated
Distribution
Product was distributed by major distribution chains nationwide.
Verify the product name, lot number, and expiration date to confirm if your tablets are affected.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Product was distributed by major distribution chains nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 20 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0089-2023 (December 7, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0089-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.